Fifty-five patients ( age , 16 to 67 years ; 43 women ) with longstanding facial palsy were randomly treated with either onabotulinumtoxinA ( n = 25 ) or abobotulinumtoxinA ( n = 30 ) injections into the nonparalyzed side .